TY - JOUR
TI - The corona-virus disease 2019 pandemic compromised routine care for
hypertension: a survey conducted among excellence centers of the
European Society of Hypertension
AU - Weber, Thomas
AU - Januszewicz, Andrzej
AU - Rosei, Enrico Agabiti and
AU - Tsioufis, Konstantinos
AU - Okorie, Michael
AU - Stergiou, George S. and
AU - Volpe, Massimo
AU - Kreutz, Reinhold
AU - Abraham, Gyorgy
AU - Azizi,
AU - Michel
AU - Barna, Istvan
AU - Barroso, Weimar Kunz Sebba
AU - Brguljan,
AU - Jana
AU - Chapman, Neil
AU - De Backer, Tine
AU - Dorobantu, Maria and
AU - Eckert, Siegfried
AU - Gaciong, Zbigniew
AU - Giannattasio, Cristina and
AU - Glover, Mark
AU - Gottsaeter, Anders
AU - Grassos, Charalampos
AU - Jarai,
AU - Zoltan
AU - Aguila, Fernando Jaen
AU - Kahan, Thomas
AU - Lopez-Sublet,
AU - Marilucy
AU - Lovic, Dragan
AU - Lurbe, Empar
AU - Makris, Thomas K. and
AU - Mallamaci, Francesca
AU - Manolis, Athanasios J.
AU - Marketou, Maria and
AU - Mazza, Alberto
AU - Mediavilla, Juan Diego
AU - Muiesan, Maria Lorenza and
AU - Muxfeldt, Elizabeth Silaid
AU - Nasr, Edgar
AU - Papadakis, Ioannis and
AU - Parounak, Zelveian
AU - Obregon, Sebastian
AU - Okorie, Michael and
AU - Oliveras, Anna
AU - Pontremoli, Roberto
AU - Raev, Dimitar
AU - Rajkumar,
AU - Chakravarthi
AU - Redon, Josep
AU - Robles, Nicolas Roberto
AU - Rump, Lars
AU - Christian
AU - Sarzani, Riccardo
AU - Sierra, Cristina
AU - Sirenko, Yuriy
AU - and Stojanov, Vesna
AU - Tikkanen, Ilkka
AU - Vaclavik, Jan
AU - Veglio,
AU - Franco
AU - Viigimaa, Margus
AU - Webb, David
AU - Zebekakis, Pantelis and
AU - Zweiker, Robert
AU - European Soc Hypertension Corona-V
JO - JOURNAL OF HYPERTENSION
PY - 2021
VL - 39
TODO - 1
SP - 190-195
PB - Lippincott, Williams & Wilkins
SN - -
TODO - 10.1097/HJH.0000000000002703
TODO - Covid-19; blood pressure; hypertension routine care; renin-angiotensin
system inhibitors
TODO - Background: The Covid-19 pandemic caused a shutdown of healthcare
systems in many countries. We explored the impact on hypertension care
in the Excellence Center (EC) network of the European Society of
Hypertension. Methods: We conducted a 17-question electronic survey
among ECs. Results: Overall, 52 ECs from 20 European and three
non-European countries participated, providing hypertension service for
a median of 1500 hypertensive patients per center per year. Eighty-five
percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16).
The number of patients treated per week decreased by 90%: from a median
of 50 (range 10-400) before the pandemic to a median of 5.0 (range
0-150) during the pandemic (P < 0.0001). 60% of patients (range
0-100%) declared limited access to medical consultations. The majority
of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a
median of 63% (range 0-100%) of the patients were regularly performing
home BP monitoring. In the majority (75%) of the ECs, hypertension
service returned to normal after the first wave of the pandemic. In 66%
of the ECs, the physicians received many questions regarding the use of
renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy
(in a few patients) either by patients or physicians was reported in 27
and 36.5% of the ECs. Conclusion: Patient care in hypertension ECs was
compromised during the Covid-19-related shutdown. These data highlight
the necessity to develop new strategies for hypertension care including
virtual clinics to maintain services during challenging times.
ER -